Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology and Pharmacology of Drugs for Cancer
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
Regulation of ventral hippocampal system function
Microbial Metabolic Toxicity Drives Colon Cancer
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
Neural Substrates of Learning Deficit Due to Pcp Abuse
Recently added grants:
Projecting the Epidemiologic and Economic Impact of HIV Prevention Efforts in the Context of Other Sexually Transmitted Infections
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population control
Low dose IL-2 and human regulatory T cells
Host-virus interactions in the control of filovirus entry
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42202-13-0-1
Application #
7581693
Study Section
Project Start
2004-04-01
Project End
2011-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/ Iit Research Institute
$1,741,870
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David /
$1,272,233
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/
Comments
Be the first to comment on this grant